Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 12, 2006, Pages 3245-3248

  Simoni, Daniele ^a   Roberti, Marinella ^b   Invidiata, Francesco Paolo ^c   Aiello, Enrico ^c   Aiello, Stefania ^c   Marchetti, Paolo ^a   Baruchello, Riccardo ^a   Eleopra, Marco ^a   Di Cristina, Antonietta ^d   Grimaudo, Stefania ^d   Gebbia, Nicola ^e   Crosta, Lucia ^f   Dieli, Francesco ^c   Tolomeo, Manlio ^d  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Divisione di Ematologia   (Italy)

^e Policlinico   (Italy)

^f NONE   (Italy)

Author keywords

Anticancer agents; Cell cycle analysis; Resveratrol analogues

Indexed keywords

3,4',5 TRIMETHOXYSTILBENE; ANTINEOPLASTIC AGENT; PICEATANNOL; PTEROSTILBENE; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROMYELOCYTIC LEUKEMIA;

ANTIMONY; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; HL-60 CELLS; HUMANS; MOLECULAR STRUCTURE; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646171087     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.03.028     Document Type: Article

References (27)

1. Burns J., Yokota T., Ashihara H., Lean M.E.J., and Crozier A. J. Agric. Food Chem. 50 (2002) 3337
2. Fremont L. Life Sci. 66 (2000) 663
3. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.H.S., Farnworth R.N., Kinghorn A.D., Metha R.G., Moon R.C., and Pezzuto J.M. Science 275 (1997) 218
4. Clement M.V., Hirpara J.L., Chawdhury S.H., and Pervaiz S. Blood 92 (1998) 996
5. Huang C., Ma W.Y., Goranson A., and Dong Z. Carcinogenesis 20 (1999) 237
6. Surh Y.J., Hurh Y.J., Kang J.Y., Lee E., Kong G., and Lee S.J. Cancer Lett. 140 (1999) 1
7. Arends M.J., and Wyllie A.H. Int. Rev. Exp. Pathol. 32 (1991) 223
8. Daniel P.T. Leukemia 14 (2000) 2035
9. Hickman J.A. Eur. J. Cancer 32A (1996) 921
10. Hannun Y.A. Blood 89 (1997) 1845
11. Prokop A., Wieder T., Sturm I., Essman F., Seeger K., Wutcher C., Ludwig W.-D., Henze G., Dörken B., and Daniel P.T. Leukemia 14 (2000) 1606
12. Raisova M., Bektas M., Wieder T., Daniel P., Eberle J., Orfanos C.E., and Geilen C.C. FEBS Lett. 473 (2000) 27
13. Pettit G.R., Grealish M.P., Jung M.K., Hamel E., Pettit R.K., Chapuis J.C., and Schmidt J.M. J. Med. Chem. 45 (2002) 2534
14. Kim S., Ko H., Park J.E., Jung S., Lee S.K., and Chun Y.J. J. Med. Chem. 45 (2002) 160
15. Thakkar K., Geahlen R.L., and Cushman M. J. Med. Chem. 36 (1993) 2950
16. Cushman M., Nagarathnam D., Gopal D., He H.M., Lin C.M., and Hamel E. J. Med. Chem. 35 (1992) 2293
17. Roberti M., Pizzirani D., Simoni D., Rondanin R., Baruchello R., Bonora C., Buscemi F., Grimaudo S., and Tolomeo M. J. Med. Chem. 46 (2003) 3546
18. Tolomeo M., Grimaudo S., Di Cristina A., Roberti M., Pizzirani D., Meli M., Dusonchet L., Gebbia N., Abbadessa V., Crosta L., Baruchello R., Grisolia G., Invidiata F., and Simoni D. Int. J. Biochem. Cell Biol. 37 (2005) 1709
19. Gosslau A., Chen M., Ho C.-T., and Chen K.Y. Br. J. Cancer 92 (2005) 513
20. Murias M., Handler N., Erker T., Pleban K., Ecker G., Saiko P., Szekeres T., and Jäger W. Bioorg. Med. Chem. 12 (2004) 5571
21. 13C NMR: δ 19.6, 115.6, 123.8, 126.8, 127.0, 127.6, 127.8, 130.0, 135.3.
22. Wyrzykiewicz E., Blaszczyk A., and Kedzia B. Farmaco 55 (2000) 151
23. Kim S., Min S.Y., Lee S.K., and Cho W.-J. Chem. Pharm. Bull. 51 (2003) 516
24. 13C NMR: δ 55.3, 56.0, 61.0, 99.8, 106.2, 106.7, 130.0, 130.5, 139.3, 152.9, 160.7.
25. Koh D., Park K.H., Jung J., Yang H., Mok K.H., and Lim Y. Magn. Reson. Chem. 39 (2001) 768
26. Nam N.-H. Curr. Med. Chem. 10 (2003) 1697
27. Gaukroger K., Hadfield J.A., Lawrence N.J., Nolan S., and McGown A.T. Org. Biomol. Chem. 1 (2003) 3033